Comparison of expenditure of using experimental models of carcinogenesis
DOI:
https://doi.org/10.12775/JEHS.2020.10.11.017Keywords
experimental models, carcinogenesis, ratsAbstract
Despite significant advances in the diagnosis and treatment of oncopathology, the main epidemic indicators have a negative trend.
Based on the above, a very relevant topic is the development of experimental models of carcinogenesis. The importance of scientific work in this area is increasing because in experimental conditions it is better to test new methods, diagnostics and treatment. Thus, it becomes possible to study the peculiarities of the pathogenesis of any tumor at different stages.
The purpose of the work – to study and demonstrate the strengths and weaknesses of the main experimental models of carcinogenesis for further selection of the most appropriate.
Results The main directions of carcinogenesis modeling are presented in the article. Initially, the problem was justified. The next step is described in chronological order of using the models.
Of course, the achievements of clinical and experimental oncology played an important role in the emergence of models. Thus, the first model was the effect of physical and chemical carcinogens on a laboratory animal. The latest achievement of experimental oncology is the use of stem cells in combination with genetic engineering.
No less important is the fact of comparing experimental models. We present the strengths and weaknesses of all these models.
Conclusions
1. To date, there are a large number of experimental models of carcinogenesis.
2. When planning a study, you need to calculate all the goals to be achieved and select the appropriate model.
3. The most effective and common model for ascites ovarian tumor is the transplantation of atypical cells to laboratory animals.
References
Milgrom DP, Lad NL, Koniaris LG, Zimmers TA. Bone Pain and Muscle Weakness in Cancer Patients. Curr Osteoporos Rep. 2017;15(2):76-87.
Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Novel targeted therapies for cancer cachexia. Biochem J. 2017; 474(16): 2663-2678.
Malignant neoplasms in Russia in 2017 (morbidity and mortality) / ed. HELL. Kaprina, VV Starinskogo, G.V. Petrova. M: MNIOI them. PAS. Herzen, 2018. 250 p.
Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin., 2018, vol. 0, pp. 1–31. DOI: 10.3322/caac.21492.
Siegel R.L., Miller K.D., Jemal A. Cancer statistics. 2018. CA: Cancer Journal for Clinicians, 2018, vol. 68(1), pp. 7–30. DOI: doi.org/10.3322/caac.21442.
Smirnova T.A., Ilyin E.A. Ethics of conducting biomedical research and testing. Aerospace and Environmental Medicine. 2017.Vol. 51.No. 3.P. 59–68. DOI: 10.21687 / 0233-528X-2017-51-4-59-68.
Nuremberg Code // Ethical and legal problems of clinical trials and scientific experiments on humans and animals. M., 1994. S. 42–43.
Trashkov A.P., Panchenko A.V., Vasiliev A.G., Artemenko M.R., Bogomolov B.N. Features of the growth of an experimental ascites tumor of the ovaries of rats and changes in hematological parameters in tumor-bearing animals under the influence of gemcitabine. Bulletin of the Russian Military Medical Academy. 2012; 2 (38): 90–96.
Models and methods of experimental oncology: practical. manual / ed. A.D. Timofeevsky. - M: Medgiz, 1960 .-- 246 p.
Popova NA Models of experimental oncology. Soros general review magazine. - 2000. - T. 6, No. 8. - S. 33 - 38.
Zhikhareva AA, Askarova RS Carcinogens and their effects on the human body. Youth science in the XXI century: traditions, innovations, vectors of development. - 2019 .-- T. 1. - S. 235 - 236.
Borshuk E. L. Boev V. M. Barkhatova L.A. Karpenko I.L. Kudusova L.Kh. Predictive model of oncological morbidity of the population under the influence of chemical carcinogens of the environment. Public health and habitat. - 2017. - No. 1 (286). - S. 13 -16.
Volgareva G.M. Human papillomavirus carcinogenesis. main achievements and some problems part 1. general understanding of papillomaviruses. forms of cancer associated with human papillomaviruses. Russian biotherapeutic journal. 2020; 19 (1): 6-12. https://doi.org/10.17650/1726-9784-2019-19-1-6-12.
Turner KM, Deshpande V, Beyter D, Koga T, Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson DA, Kornblum HI, Taylor MD, Kaushal S, Cavenee WK, Wechsler-Reya R, Furnari FB, Vandenberg SR, Rao PN, Wahl GM, Bafna V, Mischel PS. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017 Mar 2;543(7643):122-125. doi: 10.1038/nature21356.
Wu CC, Wang JH, Lin PC, Liang CA, Huang CY, Lien HC, Chen CY, Chou KJ, Su YC. Tumor sidedness and efficacy of first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer: A network meta-analysis. Crit Rev Oncol Hematol. 2020 Jan;145:102823. doi: 10.1016/j.critrevonc.2019.102823.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 290
Number of citations: 0